Uncertainty-Aware Multiscale Treatment Response Forecasting in Advanced Non-Small Cell Lung Cancer Using Residual-Variance Conformal Prediction
Wang, S.; Deng, L.; Ye, T.; Kinahan, P. E.; Zeng, J.; Gennari, J. H.; Bowen, S. R.
Show abstract
Voxel-level prediction of treatment response from longitudinal fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can enable spatially adaptive dose planning in advanced non-small cell lung cancer (NSCLC), but point predictions alone lack the uncertainty quantification needed for safe clinical decision-making. Standard conformal prediction (CP) provides distribution-free coverage but yields spatially uniform intervals and assumes exchangeability, an assumption violated by intra-tumoral spatial correlation. We propose a multiscale CP framework built on a re-optimized VoxelForecast generalized least squares model that explicitly captures voxel-level covariance. Variogram sensitivity analysis identified the Stable model as significantly superior to the previously used Matern family. The framework combines hierarchical nested leave-one-patient-out calibration, which restores exchangeability for valid voxel-level coverage, with residual-variance CP (VarCP), which learns a heteroscedastic, location-dependent scale to produce adaptive intervals while preserving finite-sample marginal coverage guarantees. On two prospective NSCLC trial cohorts, FLARE-RT (N=25 locally advanced, chemoradiotherapy; 11,100 voxels) and BRIGHT (N=19 metastatic, chemoimmunotherapy; 26,980 voxels), multiscale feature integration reduced voxel-level prediction error by 35% and 31%, respectively. VarCP maintained nominal coverage while producing 7-18% (FLARE-RT) and 4-8% (BRIGHT) narrower voxel-level intervals than a hierarchically calibrated standard CP baseline (paired Wilcoxon signed-rank, significant at most miscoverage levels), with comparable lesion-level gains (7-18% and 6-10%) via median-based aggregation of voxel residuals. VarCP delivers tighter yet mathematically guaranteed spatial uncertainty maps, supporting both voxel-level dose adjustment and whole-lesion treatment planning in advanced NSCLC.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Features fusion or not: harnessing multiple pathological foundation models using Meta-Encoder for downstream tasks fine-tuning 92%
- Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance 91%
- Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer 91%
Similar papers in this journal
- Histology-based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning 91%
- Early ctDNA kinetics as a dynamic biomarker of cancer treatment response 90%
- Large language models to help appeal denied radiotherapy services 89%
Similar papers in this journal
- Dual Adversarial Deconfounding Autoencoder for joint batch-effects removal from multi-center and multi-scanner radiomics data 93%
- Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: A modelling study based on longitudinal tumor measurements 92%
- Improving Rectal Tumor Segmentation with Anomaly Fusion Derived from Anatomical Inpainting: A Multicenter Study 91%
Similar papers in this journal
- TUGDA: Task uncertainty guided domain adaptation for robust generalization of cancer drug response prediction from in vitro to in vivo settings 90%
- Comprehensive evaluation of cell-type quantification methods for immuno-oncology 89%
- PiDeel: Pathway-informed deep learning model for survivalanalysis and pathological classification of gliomas 88%
Similar papers in this journal
- Bayesian combination of mechanistic modeling and machine learning (BaM3): improving personalized tumor growth predictions 88%
- LUNAR: A Deep Learning Model to Predict Glioma Recurrence Using Integrated Genomic and Clinical Data 88%
- Subpopulation-specific Machine Learning Prognosis for Underrepresented Patients with Double Prioritized Bias Correction 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.